Kintara Therapeutics Inc (NASDAQ:KTRA) Reports Q3 Earnings: Stock Reacts Positively

May 16, 2022

Biopharmaceutical firm Kintara Therapeutics Inc (NASDAQ:KTRA) is a company that could well come into focus this morning among investors considering the fact that its stock had clocked gains of as much as 11% this past Friday. Trading Data      On Friday, KTRA stock moved up 11.37% to $0.1880 with more than 9.11 million shares, compared to its average volume of 2.41 million shares. The stock moved within a range of $0.1540…

Read More >>